TABLE 1.
Gender Diagnosis Status, MGMT and IDH1 by Diagnosis
| Diagnosis |
||||
|---|---|---|---|---|
| AA |
GBM |
|||
| N | % | N | % | |
| Total # patients | 199 | 16.85 | 982 | 83.15 |
| Gender | ||||
| Female | 75 | 6.35 | 398 | 33.70 |
| Male | 124 | 10.50 | 584 | 49.45 |
| Diagnosis status | ||||
| Newly diagnosed | 103 | 8.72 | 647 | 54.78 |
| Recurrent | 96 | 8.13 | 335 | 28.37 |
| MGMT promoter methylation status | ||||
| Identified | 115 | 9.74 | 451 | 38.19 |
| Not identified | 84 | 7.11 | 531 | 44.96 |
| IDH1 diagnostics | ||||
| Missing | 148 | 12.53 | 653 | 55.29 |
| Intact | 34 | 2.88 | 311 | 26.33 |
| Mutation | 17 | 1.44 | 18 | 1.52 |
AA, anaplastic astrocytoma; GBM, glioblastoma; MGMT, O6-methylguanine-DNA methyltransferase.